Vaughan K, McConaghy N, Wolf C, Myhr C, Black T
Department of Psychological Medicine, The University of Sydney, Australia.
Aust N Z J Psychiatry. 2000 Oct;34(5):801-8. doi: 10.1080/j.1440-1614.2000.00813.x.
The objective of this study was to investigate the readmission rate, and the level of patient disturbance and community care associated with readmission following Community Treatment Orders (CTOs) in New South Wales, Australia.
The readmission rates of all patients given CTOs within a 4-year period and a matched comparison group were investigated. The following factors were compared before, during and following a CTO: medication non-compliance, number of clinical services and duration of disturbed behaviour preceding hospitalisations.
Of 123 patients on CTOs (mean length, 288 days; SD, 210 days), 38 were readmitted during the CTO, the majority in the first 3 months and a further 21 patients were readmitted following termination of the CTO. Evidence of lower severity of illness in the comparison patients prevented meaningful evaluation of the readmission rates of the two groups. While on CTOs, patients receiving depot medications showed high compliance and a significantly reduced readmission rate compared with that of patients receiving oral medications. In the 2 months prior to hospitalisations during CTOs, compared with those before or after CTOs, patients received more frequent consultations and showed a shorter duration of medication non-compliance and disturbed behaviour. The level of services in the 3 months following discharge were comparable for patients on CTOs and the comparison group.
CTOs may reduce rehospitalisations by use of depot medication. Earlier and possibly more frequent readmissions in the CTO group shortened the disturbance associated with illness recurrence. It would appear that to establish a control group with equivalent severity of disorder necessary to evaluate the impact of CTOs requires a random allocation design.
本研究旨在调查澳大利亚新南威尔士州社区治疗令(CTO)下达后的再入院率,以及与再入院相关的患者干扰水平和社区护理情况。
对4年内所有接受CTO治疗的患者以及一个匹配的对照组的再入院率进行了调查。在下达CTO之前、期间和之后,对以下因素进行了比较:药物治疗不依从性、临床服务次数以及入院前行为紊乱的持续时间。
在123名接受CTO治疗的患者中(平均时长288天;标准差210天),38人在CTO期间再次入院,大多数发生在前3个月,另有21名患者在CTO终止后再次入院。对照患者病情较轻的证据使得对两组再入院率进行有意义的评估变得困难。在接受CTO治疗期间,与接受口服药物的患者相比,接受长效药物治疗的患者依从性较高,再入院率显著降低。在CTO期间入院前的2个月里,与CTO之前或之后相比,患者接受的会诊更频繁,药物治疗不依从和行为紊乱的持续时间更短。CTO治疗组患者出院后3个月的服务水平与对照组相当。
CTO可能通过使用长效药物来减少再次住院的情况。CTO组中更早且可能更频繁的再入院缩短了与疾病复发相关的干扰时间。似乎要建立一个具有同等疾病严重程度的对照组来评估CTO的影响,需要采用随机分配设计。